<DOC>
	<DOCNO>NCT01092338</DOCNO>
	<brief_summary>Optimal vitamin D ( vit D ) concentration metabolism essential normal immune function , growth , muscle , bone , inflammatory status child , adolescent adult HIV/AIDS . The impact vit D supplementation evaluate safety efficacy use clinically important outcome , overcome critical barrier use vit D supplementation research clinical care . Inexpensive easy administer , vit D supplementation may prove effective feasible treatment symptom prevention side effect people age live HIV/AIDS US around world .</brief_summary>
	<brief_title>Vitamin D Dose Finding Study</brief_title>
	<detailed_description>The key role vitamin D ( vit D ) maintain optimal bone health long recognize , role modulate innate immune response inflammatory reaction recently come active investigation . As , vit D increasingly frequently choose prescribe high dose dietary supplement , think improve immune inflammatory status healthy people age , chronic disease include HIV/AIDS . Vit D also calciotrophic function essential bone health , poor vit D status contribute osteopenia/osteoporosis associate antiretroviral therapy ( ART ) . Vit D may improve insulin/glucose/lipid metabolism , blood pressure risk cancer , may complicate HIV/AIDS treatment . Poor vit D status common patient HIV/AIDS age factor age , skin pigment , lactose intolerance sun exposure alter risk vit D deficiency . In multicenter U.S. REACH study adolescent ( 72 % African American ) , without HIV , show 87 % low serum 25D concentration ( &lt; 15 ng/mL ) , compare 34 % recent sample healthy African American child Philadelphia . Young African Americans disproportionately affected HIV infection US ( ~ 55 % among person HIV age 13 24 year African American ) , also high risk vit D deficiency . Vit D therapy great promise improve major medical condition quality life patient HIV/AIDS , yet potential role vit D treatment HIV/AIDS formally test . Well-designed randomized trial urgently need determine vit D supplementation safety efficacy . The investigator propose two-phase study establish safety efficacy high dose vit D supplementation child adult HIV/AIDS . In Study Phase I , safety efficacy two oral vit D3 dose ( 4000 7000 IU/d ) determine 12 week 44 subject age 5.0 24.9 . The key safety measure concurrently elevate serum calcium 25D concentration . Efficacy evaluate serum 25D concentration cathelicidin ( innate immune , antimicrobial protein ) mRNA expression . Study Phase II 12 month , double blind , randomize , placebo control supplementation study ( n=52 ) . Key outcomes include safety longterm 25D concentration within goal range ( 32 160 ng/mL ) , improve cathelicidin mRNA expression , measure bone , muscle , inflammation , growth body composition status , HIV/AIDS disease severity . Based evidence promise , vit D clearly deserve among first nutrient evaluate National Center Complimentary Alternative Medicine ( NCCAM ) HIV research program .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>1 . HIV seropositive diagnose standard technique 2 . Age perinatallyacquired HIV/AIDS Group ( PA subject ) : 5.0 24.9 3 . Age nonperinatallyacquired HIV/AIDS Group ( nonPA subject ) : 15.0 24.9 4 . In usual state good health ( hospitalization , emergency room unscheduled acute illness visit 2 week prior ) 5 . Subject and/or family commitment 3month study 1 . Other chronic health condition may affect growth , dietary intake , and/or nutritional status 2 . Pregnancy 3 . Participation another HIV intervention study impact 25D serum concentration 4 . Use vit D supplementation ( subject willing discontinue supplementation become eligible 2month washout period ) 5 . Baseline elevate serum calcium concentration 6 . NonEnglish speaking</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>24 Years</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Human Immunodeficiency Virus</keyword>
	<keyword>Acquired Immune Deficiency Syndrome</keyword>
	<keyword>Vitamin D</keyword>
	<keyword>HIV</keyword>
	<keyword>Complementary therapy</keyword>
</DOC>